ArticleOncoTargets and therapy2014

The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells.

Junxia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.